Depression in adults with sickle cell disease: a systematic review of the methodological issues in assessing prevalence of depression.
Depression
Methodology
Prevalence
Sickle cell disease
Journal
BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676
Informations de publication
Date de publication:
06 Apr 2021
06 Apr 2021
Historique:
received:
02
07
2020
accepted:
28
02
2021
entrez:
7
4
2021
pubmed:
8
4
2021
medline:
10
4
2021
Statut:
epublish
Résumé
Sickle cell disease (SCD) as other chronic medical conditions is commonly complicated by depression or other psychiatric symptoms. Results reported in studies present a large variation. Thus, synthetic data are needed to understand impact of depression in adults with SCD. The aim of this literature review is to analyse the methodology used in the studies assessing depression and discuss the different prevalence levels reported. Studies involving adults with SCD from 1999 to 2018 were included when providing data on prevalence of depression. It was defined by a psychometric assessment, a structured interview, or a medical record review. PRISMA recommendations were followed. 36 studies are included accordingly to our methodology. Prevalence variation is large, from 0% to more than 85%. We find that the type of assessment tool used plays a major role in this between studies variation. Also, methodological issues arise with respect to psychometric assessment. Moreover, differences emerge between continents, setting of recruitment or time of assessment. All these issues are discussed to provide insight on depression in adults with sickle cell disease. PROSPERO Registration CRD42018100684.
Sections du résumé
BACKGROUND
BACKGROUND
Sickle cell disease (SCD) as other chronic medical conditions is commonly complicated by depression or other psychiatric symptoms. Results reported in studies present a large variation. Thus, synthetic data are needed to understand impact of depression in adults with SCD. The aim of this literature review is to analyse the methodology used in the studies assessing depression and discuss the different prevalence levels reported.
METHODS
METHODS
Studies involving adults with SCD from 1999 to 2018 were included when providing data on prevalence of depression. It was defined by a psychometric assessment, a structured interview, or a medical record review. PRISMA recommendations were followed.
RESULTS
RESULTS
36 studies are included accordingly to our methodology. Prevalence variation is large, from 0% to more than 85%. We find that the type of assessment tool used plays a major role in this between studies variation. Also, methodological issues arise with respect to psychometric assessment. Moreover, differences emerge between continents, setting of recruitment or time of assessment.
CONCLUSION
CONCLUSIONS
All these issues are discussed to provide insight on depression in adults with sickle cell disease.
TRIAL REGISTRATION
BACKGROUND
PROSPERO Registration CRD42018100684.
Identifiants
pubmed: 33823930
doi: 10.1186/s40359-021-00543-4
pii: 10.1186/s40359-021-00543-4
pmc: PMC8025551
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
54Références
Br J Haematol. 2016 Jul;174(1):136-47
pubmed: 26991317
J Affect Disord. 2013 Sep 5;150(2):384-8
pubmed: 23759278
Cult Med Psychiatry. 1978 Dec;2(4):343-57
pubmed: 729393
Blood Adv. 2017 Oct 12;1(23):1983-1992
pubmed: 29296845
Clin J Pain. 2013 Apr;29(4):317-23
pubmed: 23246997
Clin J Pain. 2016 Dec;32(12):1076-1085
pubmed: 26889615
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
Lancet. 2007 Sep 8;370(9590):851-8
pubmed: 17826170
Lancet. 2013 Jan 12;381(9861):142-51
pubmed: 23103089
J Glob Health. 2019 Dec;9(2):020417
pubmed: 31893031
Indian J Med Res. 2020 Jun;151(6):505-508
pubmed: 32719221
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Behav Res Ther. 1997 Jan;35(1):79-89
pubmed: 9009048
Gen Hosp Psychiatry. 2007 Mar-Apr;29(2):147-55
pubmed: 17336664
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Int J Palliat Nurs. 2018 May 2;24(5):246-255
pubmed: 29792764
BMC Psychiatry. 2010 Jun 07;10:40
pubmed: 20529274
J Hosp Med. 2011 May;6(5):248-55
pubmed: 21661098
Age Ageing. 2014 Jul;43(4):510-4
pubmed: 24603284
J Pediatr Hematol Oncol. 2010 Jul;32(5):345-9
pubmed: 20485202
Health Qual Life Outcomes. 2017 Sep 5;15(1):176
pubmed: 28874154
Global Health. 2010 Feb 20;6:2
pubmed: 20170540
J Affect Disord. 2018 Dec 1;241:461-468
pubmed: 30149333
Int J Psychiatry Med. 2016 Jul;51(5):456-466
pubmed: 28629283
PLoS One. 2013;8(3):e58067
pubmed: 23469262
Soc Sci Med. 2016 Jul;161:27-36
pubmed: 27239705
Clin Neuropsychol. 2018 Jan;32(1):81-97
pubmed: 28632024
Health Serv Res. 2003 Aug;38(4):1081-102
pubmed: 12968818
J Am Assoc Nurse Pract. 2015 Aug;27(8):441-9
pubmed: 25703174
Psychosom Med. 2008 Feb;70(2):192-6
pubmed: 18158366
Pain. 2008 Aug 15;138(1):11-21
pubmed: 18093737
Psychosomatics. 2002 Sep-Oct;43(5):386-93
pubmed: 12297607
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Ann Behav Med. 2000 Spring;22(2):149-57
pubmed: 10962708
Med J Aust. 2009 Apr 6;190(S7):S54-60
pubmed: 19351294
Stigma Health. 2017 Nov;2(4):271-280
pubmed: 29404408
Lancet. 2009 Aug 22;374(9690):609-19
pubmed: 19640579
BMC Psychol. 2016 Nov 10;4(1):53
pubmed: 27832817
J Behav Med. 1999 Apr;22(2):115-26
pubmed: 10374138
Gen Hosp Psychiatry. 2007 Sep-Oct;29(5):409-16
pubmed: 17888807
Pak J Med Sci. 2018 Jul-Aug;34(4):929-933
pubmed: 30190755
Psychol Med. 1983 Aug;13(3):595-605
pubmed: 6622612
N Engl J Med. 1985 Dec 19;313(25):1571-5
pubmed: 2415821
J Nerv Ment Dis. 2000 Oct;188(10):662-70
pubmed: 11048815
Front Physiol. 2020 May 20;11:435
pubmed: 32508672
Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):407-13
pubmed: 18774423
Eur J Neurol. 2003 Mar;10(2):147-52
pubmed: 12603289
Rev Med Interne. 2015 May 11;36(5 Suppl 1):5S3-84
pubmed: 26007619
N Engl J Med. 1995 May 18;332(20):1317-22
pubmed: 7715639